Trial Profile
Drug Interaction Profile of Momelotinib
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Sep 2015
Price :
$35
*
At a glance
- Drugs Momelotinib (Primary) ; Midazolam; Rifampicin; Ritonavir; Rosuvastatin
- Indications Essential thrombocythaemia; Myelofibrosis; Myeloproliferative disorders; Non-small cell lung cancer; Pancreatic cancer; Polycythaemia vera
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Gilead Sciences
- 14 Sep 2015 New trial record